Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis

Digestion

Volumn 84, Issue 1, 2011, Pages 29-35

  Stallhofer, Johannes ^a   Denk, Gerald Ulrich ^a   Glas, Jürgen ^a,b   Laubender, Rüdiger Paul ^a   Göke, Burkhard ^a   Rust, Christian ^a   Brand, Stephan ^a   Pusl, Thomas ^a,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c KLINIKUM AUGSBURG   (Germany)

Author keywords

Autoimmune disease; IL2; IL21; Polymorphism; Primary biliary cirrhosis; Primary sclerosing cholangitis; Th17 cells; Ulcerative colitis

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 21;

ADULT; AGED; ARTICLE; AUTOSOME; BILE DUCT CARCINOMA; CHROMOSOME 4Q27; CLINICAL ASSESSMENT; COLITIS; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE REPLICATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INDETERMINATE COLITIS; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; CHOLANGITIS, SCLEROSING; COHORT STUDIES; COLITIS, ULCERATIVE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-2; INTERLEUKINS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 79551622962     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000321619     Document Type: Article

References (44)

1. Chapman R, Cullen S: Etiopathogenesis of primary sclerosing cholangitis. World J Gastroenterol 2008; 14: 3350-3359.
2. Gershwin ME, Mackay IR: The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008; 47: 737-745. (Pubitemid 351280742) (Pubitemid 351280742)
3. Loftus EV Jr, Harewood GC, Loftus CG, et al: PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005; 54: 91-96. (Pubitemid 40007225) (Pubitemid 40007225)
4. Loftus EV, Sandborn WJ, Lindor KD, et al: Interactions between chronic liver disease and inflammatory bowel disease. Inflamm Bowel Dis 1997; 3: 288-302. (Pubitemid 127726457) (Pubitemid 127726457)
5. Zhernakova A, van Diemen CC, Wijmenga C: Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009; 10: 43-55.
6. Hirschfield GM, Liu X, Xu C, et al: Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009; 360: 2544-2555.
7. Karlsen TH, Franke A, Melum E, et al: Genome- wide association analysis in primary sclerosing cholangitis. Gastroenterology 2010; 138: 1102-1111.
8. Festen EA, Goyette P, Scott R, et al: Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis. Gut 2009; 58: 799-804.
9. Glas J, Brand S: Consolidation of evidence for association of the KIAA1109-TENR-IL2- IL21 rs6822844 variant with Crohn's disease response. Am J Gastroenterol 2010; 105: 1206-1207.
10. Glas J, Stallhofer J, Ripke S, et al: Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease. Am J Gastroenterol 2009; 104: 1737-1744.
11. Marquez A, Orozco G, Martinez A, et al: Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease. Am J Gastroenterol 2009; 104: 1968-1975.
12. van Heel DA, Franke L, Hunt KA, et al: A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007; 39: 827-829. (Pubitemid 47014494) (Pubitemid 47014494)
13. Barrett JC, Clayton DG, Concannon P, et al: Genome-wide association study and metaanalysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009; 41: 703-707.
14. Zhernakova A, Alizadeh BZ, Bevova M, et al: Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am J Hum Genet 2007; 81: 1284-1288. (Pubitemid 350211457) (Pubitemid 350211457)
15. Todd JA, Walker NM, Cooper JD, et al: Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes, Nat Genet 2007; 39: 857-864. (Pubitemid 47018195) (Pubitemid 47018195)
16. Daha NA, Kurreeman FA, Marques RB, et al: Confirmation of STAT4, IL2/IL21, and CTLA4 polymorphisms in rheumatoid arthritis. Arthritis Rheum 2009; 60: 1255-1260.
17. Maiti AK, Kim-Howard X, Viswanathan P, et al: Confirmation of an association between rs6822844 at the IL2-IL21 region and multiple autoimmune diseases: evidence of a general susceptibility locus. Arthritis Rheum 2010; 62: 323-329.
18. Liu Y, Helms C, Liao W, et al: A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 2008; 4:e1000041.
19. Albers HM, Kurreeman FA, Stoeken-Rijsbergen G, et al: Association of the autoimmunity locus 4q27 with juvenile idiopathic arthritis. Arthritis Rheum 2009; 60: 901-904.
20. Hinks A, Eyre S, Ke X, et al: Association of the AFF3 gene and IL2/IL21 gene region with juvenile idiopathic arthritis. Genes Immun 2010; 11: 194-198.
21. Sawalha AH, Kaufman KM, Kelly JA, et al: Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann Rheum Dis 2008; 67: 458-461. (Pubitemid 351498423) (Pubitemid 351498423)
22. Saarinen S, Olerup O, Broome U: Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol 2000; 95: 3195-3199.
23. Gershwin ME, Selmi C, Worman HJ, et al: Risk factors and comorbidities in primary biliary cirrhosis: a controlled interviewbased study of 1032 patients. Hepatology 2005; 42: 1194-1202. (Pubitemid 43112687) (Pubitemid 43112687)
24. Kaplan MM, Gershwin ME: Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-1273. (Pubitemid 41345948) (Pubitemid 41345948)
25. Weismuller TJ, Wedemeyer J, Kubicka S, et al: The challenges in primary sclerosing cholangitis - aetiopathogenesis, autoimmunity, management and malignancy. J Hepatol 2008; 48(suppl 1):S38-S57.
26. Barrett JC, Fry B, Maller J, et al: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265. (Pubitemid 40202029) (Pubitemid 40202029)
27. Fay MP: Confidence intervals that match Fisher's exact or Blaker's exact tests. Biostatistics 2010; 11: 373-374.
28. Chen B, Wilkening S, Drechsel M, et al: SNP-tools: a compact tool package for analysis and conversion of genotype data for MSExcel. BMC Res Notes 2009; 2: 214.
29. Henckaerts L, Fevery J, Van Steenbergen W, et al: CC-type chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitis. Inflamm Bowel Dis 2006; 12: 272-277.
30. Saich R, Chapman R: Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. World J Gastroenterol 2008; 14: 331-337. (Pubitemid 351320842) (Pubitemid 351320842)
31. Bergquist A, Lindberg G, Saarinen S, et al: Increased prevalence of primary sclerosing cholangitis among first-degree relatives. J Hepatol 2005; 42: 252-256. (Pubitemid 40143473) (Pubitemid 40143473)
32. Bergquist A, Montgomery SM, Bahmanyar S, et al: Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2008; 6: 939-943.
33. Sgouroudis E, Albanese A, Piccirillo CA: Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice. J Immunol 2008; 181: 6283-6292.
34. Yamanouchi J, Rainbow D, Serra P, et al: Interleukin- 2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 2007; 39: 329-337. (Pubitemid 46328484) (Pubitemid 46328484)
35. McGuire HM, Vogelzang A, Hill N, et al: Loss of parity between IL-2 and IL-21 in the NOD Idd3 locus. Proc Natl Acad Sci USA 2009; 106: 19438-19443.
36. Zheng SG, Wang J, Wang P, et al: IL-2 is essential for TGF-beta to convert naïve CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 2007; 178: 2018-2027. (Pubitemid 46233398) (Pubitemid 46233398)
37. Laurence A, Tato CM, Davidson TS, et al: Interleukin- 2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007; 26: 371-381. (Pubitemid 46413906) (Pubitemid 46413906)
38. Sadlack B, Merz H, Schorle H, et al: Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75: 253-261. (Pubitemid 23320289) (Pubitemid 23320289)
39. Bo X, Broome U, Remberger M, et al: Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis. Gut 2001; 49: 131-141. (Pubitemid 32601890) (Pubitemid 32601890)
40. Malek TR: The biology of interleukin-2. Annu Rev Immunol 2008; 26: 453-479. (Pubitemid 351600382) (Pubitemid 351600382)
41. Saraiva M, O'Garra A: The regulation of IL- 10 production by immune cells. Nat Rev Immunol 2010; 10: 170-181.
42. Yang L, Anderson DE, Baecher-Allan C, et al: IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008; 454: 350-352.
43. Li Y, Yee C: IL-21 mediated Foxp3 suppression leads to enhanced generation of antigen- specific CD8+ cytotoxic T lymphocytes. Blood 2008; 111: 229-235.
44. Peluso I, Fantini MC, Fina D, et al: IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J Immunol 2007; 178: 732-739. (Pubitemid 46095145) (Pubitemid 46095145)